FRANCISCO MARTÍN MOLINA-rekin lankidetzan egindako argitalpenak (9)

2023

  1. Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 75-92

2021

  1. Improved functionality of integration-deficient lentiviral vectors (IDLVs) by the inclusion of IS2 protein docks

    Pharmaceutics, Vol. 13, Núm. 8

2018

  1. The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes

    Molecular Therapy - Nucleic Acids, Vol. 13, pp. 16-28

2016

  1. Absence of WASp enhances hematopoietic and megakaryocytic differentiation in a human embryonic stem cell model

    Molecular Therapy, Vol. 24, Núm. 2, pp. 342-353

2015

  1. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells

    Molecular Therapy, Vol. 23, Núm. 1, pp. 158-170

2012

  1. Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification

    Stem Cells and Development, Vol. 21, Núm. 9, pp. 1549-1558

  2. Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors

    PLoS ONE, Vol. 7, Núm. 6

2008

  1. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis

    Gene Therapy, Vol. 15, Núm. 12, pp. 930-941

2006

  1. Transplantation of human CD34+ stem cells from umbilical cord blood to rats with thioacetamide-induced liver cirrhosis

    Xenotransplantation, Vol. 13, Núm. 6, pp. 529-535